Managing diabetes key to prevent dementia: Study

An Indian-origin scientist has found that reducing the risk of dementia in Alzheimer’s is possible by keeping diabetes under control.

Narendra Kumar, an associate professor at Texas A&M University in the US, spearheaded a study featured in the ‘American Society for Biochemistry and Molecular Biology’ journal, uncovering a robust connection between diabetes and Alzheimer’s disease.

“Implementing preventative or mitigative measures for diabetes could potentially stall or mitigate the advancement of dementia symptoms in Alzheimer’s,” he emphasized.

Diabetes and Alzheimer’s represent two burgeoning health challenges worldwide. Diabetes disrupts the body’s energy conversion from food and affects approximately one in ten US adults. Meanwhile, Alzheimer’s ranks among the top ten leading causes of death in the US, as highlighted in the research.

The team delved into how dietary patterns might influence Alzheimer’s progression in individuals with diabetes.

Their investigation unveiled that a high-fat diet diminishes the expression of Jak3, a specific protein in the gut. Mice lacking this protein showcased a cascade of inflammation from the intestines to the liver and brain. Consequently, these mice exhibited Alzheimer’s-like manifestations in the brain alongside cognitive decline.

The researchers propose that the route from the gut to the brain involves the liver. “As the primary metabolizer of our dietary intake, we hypothesize that the pathway from gut to brain involves the liver,” explained Kumar.

Their long-standing exploration of Jak3’s functions revealed that alterations in its expression due to dietary factors can lead to intestinal permeability, resulting in chronic inflammation, diabetes, diminished brain capacity to eliminate toxins, and dementia-like symptoms akin to Alzheimer’s disease.

Vitamin B12 Deficiency Sensor Developed to Detect Dementia, Alzheimer Disease in Minutes

In old-age, the frequent occurrence of B12 deficiency could lead to dementia and even Alzheimer’s disease as the body metabolism fails to absorb the vitamin from the diet, requiring an early medical intervention.

To help detect B12 deficieny early, Australia’s University of Adelaide researchers have developed a first of its kind optical sensor using a technique called Raman spectroscopy that can detect vitamin B12 in diluted human blood – a first step towards a low-cost, portable, broadscale vitamin B12 deficiency test.

The sensor, still at proof-of-concept stage, has wide-reaching potential applications. It enables doctors in tracking vitamin B12 levels in high-risk patients and provide an early intervention – to top up immediately vitamin B12 levels when low. Current tests are lengthy and costly too.

Scientists in the ARC Centre of Excellence for Nanoscale BioPhotonics (CNBP), the Institute for Photonics and Advanced Sensing, and the Schools of Physical Sciences and Medicine, in their presentation today at an international biophotonics conference in Adelaide – the inaugural SPIE BioPhotonics Australasia conference — revealed the new sensor.

“Vitamin B12 deficiency has been shown to be a potential modifiable risk factor for dementia and Alzheimer’s disease and is associated with cognitive decline,” says Dr Georgios Tsiminis, Research Fellow at the University of Adelaide.

“Our sensor is an early first step towards a point-of-care solution for measuring and tracking B12 in healthy ageing adults. This would allow doctors to monitor B12 levels and intervene.”

"Currently our device could not aid in diagnosing vitamin B12 deficiency in a general practice setting… We believe this is a very promising first step towards achieving this goal," she said.

The optical sensor measures B12 in human blood in less than a minute and requires minimum preparation. This is the first demonstration of vitamin B12 being measured in human blood serum without the need for a full lab tests.

The sensor uses an optical measuring technique called Raman spectroscopy which produces a unique optical fingerprint of a target molecule, in this case vitamin B12.